Aminoacids and derivatives

<p>Stability Hygroscopic<br>Applications L-Glutamic Acid, Magnesium Salt Hydrobromide is an metabolite of L-Glutamic acid, a non-essential amino acid. Its salt form (glutamate) is an important neurotransmitter that plays a key role in long-term potentiation and is important for learning and memory. It is also a key molecule in cellular metabolism. L-Glutamic Acid, Magnesium Salt Hydrobromide has also been investigated for sedative properties as a tranquilizer.<br>References McEntee, W., et al.: Psychopharmacology, 111, 391 (1993), Manev, H., et al.: Mol. Pharmacol., 36, 106 (1989), Hamanaka, T., et al.: Toho. Igakkai. Zasshi., 20, 663 (1973);<br></p>

<p>Applications Labelled ε-Aminocaproic Acid. Used in the preparatiom of esters of 6-aminohexanoic acid as antibacterial agents. EACA is reported to inhibit chymotrypsin, Factor VIIa, lysine carbo xy peptidase, plasmin, and plasminogen activator.<br>References Dolezal, P., et al.: Pharm. Res., 10, 1015 (1993), Vavrova, K., et al.: Curr. Med. Chem., 12, 2273 (2005), Holas, T., et al.: Bioorg. Med. Chem., 14, 7671 (2006),<br></p>

<p>Applications L-Glutamine-2,3,3,4,4-d5 is the isotope labelled analog of L-Glutamine (G597000); an essential amino acid that is a crucial component of culture media that serves as a major energy source for cells in culture. L-Glutamine is very stable as a dry powder and as a frozen solution. In liquid media or stock solutions, however, L-glutamine degrades relatively rapidly. Optimal cell performance usually requires supplementation of the media with L-glutamine prior to use.<br>References Rivett, A., et al.: J. Biol. Chem., 260, 300 (1985); Watford, M., et al.: Metabolism, 49, 141 (2000); Wilmore, D., et al.: J. Nutr., 131, 2543S (2001)<br></p>

<p>Applications D-Lysine is the unnatural isomer of L-Lysine (L468895) that has the ability to reduce non-enzymatic glycation in vitro. D-Lysine also exists as polypeptide chains of poly-D-lysine, a nonspecific adhesion-promoting molecule that has the potential to be a polymeric drug carrier.<br>References Chen, Q., et al.: J. Biol. Chem., 269, 26602 (1994); Sensi, M., et al.: Diabetologia, 36, 797 (1993); Vermeersch, H., &amp; Remon, J.: J. Control. Rel., 32, 225 (1994)<br></p>

<p>Applications A labelled synthetic amino acid precursor of Norepinephrine (N674500). Antiparkinsonian.<br>References Bartholini, J., et al.: J. Pharmacol. Exp. Ther ., 193, 523 (1975), Kato, T., et al.: Biochem. Pharmacol., 36, 3051 (1987), Kawabata, A., et al.: Br J. Pharmacol., 111, 503 (1994),<br></p>